Chargement en cours...
The importance of adjuvant formulation in the development of a TB vaccine
An effective protein based vaccine for tuberculosis (TB) will require a safe and effective adjuvant. There are few adjuvants in approved human vaccines, including Alum and the oil-in-water (o/w) based emulsions MF59 (Novartis Vaccines and Diagnostics), AS03 and AS04 (GlaxoSmith Kline Biologics, GSK)...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3288309/ https://ncbi.nlm.nih.gov/pubmed/22291184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1102696 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|